Cite
APA Citation
Isakoff, S. J., Puhalla, S., Domchek, S. M., Friedlander, M., Kaufman, B., Robson, M., Telli, M. L., Diéras, V., Han, H. S., Garber, J. E., Johnson, E. F., Maag, D., Qin, Q., Giranda, V. L., & Shepherd, S. P. (2017). a randomized Phase II study of veliparib with temozolomide or carboplatin/paclitaxel versus placebo with carboplatin/paclitaxel in BRCA1/2 metastatic breast cancer: design and rationale. Future oncology, 13, 307–320. http://access.bl.uk/ark:/81055/vdc_100150239568.0x000009